A double blind comparison of alprazolam, diazepam and placebo in the treatment of anxious out-patients
- 30 June 1983
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 80 (4), 308-310
- https://doi.org/10.1007/bf00432110
Abstract
The anxiolytic effects of alprazolam, a triazolobenzodiazepine, were evaluated in a double-blind 28-day comparison with diazepam and placebo in 46 out-patients suffering from anxiety states of moderate to severe intensity. Alprazolam 1.5–3 mg per day was found to be of at least equivalent anxiolytic effect to 15–30 mg diazepam per day, and there was evidence of antidepressant activity by alprazolam, but not diazepam, in neurotic depression. Side-effects occurred least often with alprazolam and were minor in nature. Laboratory data showed no changes attributable to alprazolam even in a patient who swallowed 15 capsules (7.5 mg). It was concluded that alprazolam is a safe and effective anxiolytic which is well-tolerated and also shows some antidepressant activity.This publication has 7 references indexed in Scilit:
- MULTI-CENTER DOUBLE-BLIND EFFICACY AND SAFETY STUDY COMPARING ALPRAZOLAM, DIAZEPAM AND PLACEBO IN CLINICALLY ANXIOUS PATIENTS1981
- Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Committee on the Review of Medicines.BMJ, 1980
- Anxiolytic Efficacy of Alprazolam Compared to Diazepam and PlaceboJournal of International Medical Research, 1980
- ALPRAZOLAM COMPARED TO DIAZEPAM AND PLACEBO IN THE TREATMENT OF ANXIETY1980
- Pilot open label study with alprazolam (U31, 889) in outpatients with neurotic depression.1976
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959